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Dinuclear CuII and MnII bis-phenanthroline octanedioate complexes 10 
exhibit rapid, unprecedented nano and picomolar in vitro cytotoxicity 
against colorectal cancer lines and are less toxic than cisplatin when 
examined in vivo. The complexes are potent generators of cellular 
reactive oxygen species, avid DNA binders and induce O2 dependent 
cleavage of DNA. The Cu(II) complex was found to have self-15 
cleaving nuclease activity.  
Introduction 
The development of self-cleaving chemical nucleases is regarded 
as the paradigm of redox-active metal-based chemotherapeutics. 
DNA targeted agents capable of inducing single stranded or 20 
double stranded scission have found clinical application within 
cancer chemotherapy.1 Other applications within this class 
include; probing of DNA-specific structures, mapping of protein 
and DNA interactions, gene regulation and signal transduction.2, 3 
Thus, explorations toward the discovery and development of 25 
natural or synthetic chemical nucleases are major topics of 
interest. Redox active transition-metal-based chemical nucleases 
are particularly important due to their catalytic potential to 
support the one-electron oxidation/reduction reactions necessary 
to drive activation of C-H deoxyribose bonds. 30 
 
In the presence of Cu2+, the oxidative formation of π 
radical cations within marine-based products tambjamine E,4 
prodigiosin5 and pyrimol,6 have recently been shown to mediate 
self-cleaving DNA damage, i.e. scission which does not require 35 
the presence of added oxidant or reductant. These Cu2+ 
compounds have also demonstrated significant in vitro 
chemotherapeutic potential against leukaemia and ovarian cancer 
cells, some of which had cisplatin resistance.5, 6  
 40 
The discovery of the first synthetic chemical nuclease, 
[Cu(phen)2]2+ (phen = 1,10-phenanthroline, Figure 1), has 
sparked intensive effort toward the development of new bis-phen 
agents capable of enhanced DNA cleaving compared to the parent 
complex.7 The DNA cleaving limitations of [Cu(phen)2]2+ include 45 
(i) a high dissociation constant of the second coordinated 
phenanthroline ligand8 and (ii) the need for exogenous reductant 
to generate the active species [Cu(phen)2]+.  The dissociation 
problem (i) was solved by Meunier, Pitie et al through the advent 
of clip-phen, whereby two phenanthroline ligands are connected 50 
at the 2’ or 3’ position by a serinol bridge.9-11 Recently this 
laboratory has reported the first self-cleaving bis-phen system, 
[Cu(phen)2(phthalate)] (phthalate = o-, m-, p-phthalate, Figure 
1), capable of inducing single-stranded DNA scission in the 
absence of exogenous reductant or oxidant.12  55 
 
While [Cu(phen)2(phthalate)] complexes displayed 
excellent chemotherapeutic potential against, colon (HT29), 
breast (MC-F7) and prostate (DU145) cancer lines, their water 
solubility is poor. Of the phthalate group, the cationic, dinuclear 60 
species [Cu2(phen)4(µ2-p-phthalate)]2+ was the most active DNA-
binding, self-cleaving and chemotherapeutic agent. To that end, 
in the current study, we have investigated the application of water 
soluble Cu2+ and Mn2+ dinuclear, cationic, bis-phen octanedioate 
(oda) (Figure 1) systems as nuclease mimetics and their ability to 65 
induce cancer cell death through the redox-generation of reactive 
oxygen species (ROS). The possible formation of a π carboxyl 
radical within the Cu2+ system, which cleaves DNA by self-
activation, is also discussed.  
 70 
 
Figure 1.  Molecular strucutres of phen, odaH2 and the phthalates 
 
The title complexes [Cu2(µ2-oda)(phen)4](ClO4)2 (1) 
(Figure 2), [Mn2(µ2-oda)(phen)4(H2O)2(oda)2]2-[Mn2(µ2-75 
oda)(phen)4(H2O)2]2+ (2) (Figure 3), were prepared according to 
the literature methods by McCann and Devereux et al.13, 14 The 
coordination environment about both Cu2+ ions in 1 is 
approximately square-pyramidal with both metals being linked 
via a bridging oda ligand. In the double salt complex 2, the 80 
environment about each Mn2+ is octahedral with both metals in 
the cationic and anionic groups being bridged by oda in a similar 
fashion to 1. Whereas the Mn2+ centres of the anionic subunit in 2 
each contain a singly bound oda dianion coordinated in the apical 
position, the cationic unit contains bound water at these 85 
equivalent positions.    
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Figure 2.   Molecular strucutre the  [Cu2(µ2-oda)(phen)4]2+ cation in 
complex 1 
 100 
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Figure 3.   Molecular strucutres of the dimeric cation and anion 15 
subunits in the MnII double salt complex [Mn2(µ2-
oda)(phen)4(H2O)2(oda)2]2-[Mn2(µ2-oda)(phen)4(H2O)2]2+ (2) 
 
DNA Binding Studies 
In order to examine the interaction of compounds 1 & 2 with 20 
DNA, competitive ethidium bromide displacement and 
fluorescence quenching experiments with calf thymus DNA were 
conducted (Table 1).† Complexes 1 & 2 were found to have high 
apparent DNA binding constants (Kapp), and low fluorescence 
quenching values (Q), indicating that both systems have a high 25 
affinity for binding to DNA.  
 
Table 1. Apparent DNA binding constants (Kapp) and Q values for 1 and 2.† 
Assay conditions; C50/Kapp: final volume 2 mL, 1.2 µM EtBr, 1 µM CT-DNAp, 
10 mM TES, 0.1 mM Na2EDTA, pH 7.0; Q: final volume 2 mL, 2.0 µM EtBr, 30 
20 µM CT-DNAp, 2 mM NaOAc buffer, 9.3 mM NaCl, 0.1 mM Na2EDTA, pH 
5.0   
Complex C50* (µM) Kapp** Q‡ 
1 46.89 2.55 x 105 22.64 
2 28.46 4.20 x 105 43.13 
* C50 = concentration required to reduce fluorescence by 50% (Competitive) 
**Kapp = Ke x 1.26/C50 where Ke = 9.5 x 106 M(bp)-1 
‡ Q = equivalent concentration required to reduce fluorescence by 50% (Quenching)  35 
 
DNA Cleavage Reactions 
Relaxation of supercoiled (SC) pUC18 DNA (Form I) into open 
circular (OC, Form II) and linear (LC, Form III) conformations 
was used to quantify the relative cleavage efficiency of 1 & 2.† 40 
To examine for DNA self-cleaving ability, SC DNA was exposed 
to both complexes over a concentration range of 1-50 µM for 20 
hours in the absence of added H2O2 or reductant (Figure 4(a)). 
Complex 1 shows concentration-dependant self-cleaving of SC 
(Form I) DNA to OC (Form II) with complete depletion of the 45 
parent SC band (I→II) between 10-20 µM (lane 4 & 5 (a)). In the 
presence of added reductant (ascorbate) (Figure 4(b)) both 
complexes exhibit enhanced DNA scission during a shorter time-
frame (2hr). While both 1 & 2 induced complete relaxation to OC 
Form II (lanes 4 & 8 (b)) at 10 µM, the Cu2+ complex was found 50 
to induce efficient double stranded scission (I→III) at a 
concentration of 20 µM, characterised by the absence of a band in 
lane 5 (b). In order to identify what role molecular O2 and the 
metal cations (Cu2+/Mn2+) play within DNA cleavage, 
experiments were conducted under anaerobic conditions in an 55 
atmosphere saturated with argon and, separately, in the presence 
of 100 mM Na2EDTA (Figure 4 (c) & (d)).  The Mn2+ system 
was examined at 20 µM over two hours in the presence of 
ascorbate while the Cu2+ system was examined at 20 µM over 20 
hr without added reductant. Both complexes did not  cleave DNA 60 
in the absence of oxygen but complex 1 was found to induce 
some DNA damage in the presence of excess metal chelator 
(EDTA).     
 
Figure 4. Relaxation of pUC18 by 1 and 2.† Cleavage was carried out at 65 
37°C then analyzed by agarose gel electrophoresis† (a) 20hr incubation in the 
absence of added oxidant or reductant, lane 1: DNA alone; lanes 2-6: 1, 5, 10, 
20, 50 µM 1; lanes 7-10: 5, 10, 20, 50 µM 2. (b) 2hr incubation in the presence 
of added ascorbate (at twice complex concentration), lane 1: DNA alone; lanes 
2-5: 1, 5, 10, 20 µM 1; lanes 6-9: 1, 5, 10, 20 µM 2. (c) 20hr incubation of 20 70 
µM 1 in the absence of added oxidant or reductant, lane 1: + 100 mM 
Na2EDTA; lane 2: sat. Ar atmosphere. (d) 2hr incubation of 20 µM 2 with 
added ascorbate (at twice complex concentration), lane 1: + 100 mM 
Na2EDTA; lane 2: sat. Ar atmosphere. 
Redox Activity 75 
 
Figure 5. SOD activity profiles for complexes 1 and 2 
Table 2. SOD concentrations of complexes 1 and 2 equivalent to effect 1U of 
Bovine Erythrocyte SOD activity (50% Inhibition) and Catalase mimetic 
potential of 1 and 2 examined as a function of H2O2 disproportionation 80 
Complex Concentration Equivalent 
to 1U Bovine SOD (µM) 
Number of H2O2 molecules 
disproportionated by one molecule  
of complex in the first 5 min14 
1 1.300 0 
2 0.024  6 x 103 
Since the catalytic interaction of [Cu(phen)2]2+ and its reduced 
form, [Cu(phen)2]+, with the superoxide radical (O2•-) and 
hydrogen peroxide (H2O2) are imperitive for cleaving the 
phosphodiester backbone in DNA,15-17 we have examined the 
interaction of complexes 1 and 2 with both these species. 85 
Superoxide was generated enzymatically by the 
xanthine/xanthine-oxidase system and quantified photometrically 
by the detector nitro-blue-tetrazolium (NBT). Both complexes 1 
and 2 show potent SOD (superoxide dismutase) mimetic activity 
with the Mn2+ system being an exceptional catalyst (1U SOD = 90 
24.6 nM) (Figure 5 & Table 2). The catalase mimetic activity of 
complexes 1 & 2 were examined as a function of oxygen 
evolution. After the addition of a 30% v/v solution of H2O2 to 1 
& 2 the O2 gas evolved was quantified volumetrically  (Table 2). 
Only the Mn2+ complex (2) was capable of decomposing H2O2 95 
and its activity can also be described as exceptional in this regard 
(6 x 103 H2O2 molecules disproportionated in 5 min). Overall, 
both complexes 1 & 2 interacted with superoxide to produce 
hydrogen peroxide (I), but, only the Mn2+ complex (2) appears 
capable of disproportionates the resulting peroxide (II). 100 
 
I. 2O2•-  + 2H+ → 2H2O2 + O2 (SOD) 
II. 2H2O2  → 2H2O + O2 (CAT) 
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Antitumour Activity 
Table 3. LD50 (at ± 95% CI) values for complexes 1 and 2, the free ligand 
phen and the antitumour agent cisplatin, against colorectal cancer lines HT29, 
SW480 and SW620 over a period of 24 and 96 hours† Alan do we need 
±SD values here? Also can you include the HaCaT results 5 
here? 
 Antitumour Activity LD50 (µM)  
 HT29 SW480 SW640 
 24 hr 96 hr 24 hr 96 hr 24 hr 96 hr 
phen <200 9.240 <200 10.70 160.00 10.700 
1 9.610 >0.001 11.30 0.220 31.00 1.220 
2 108.00 0.092 7.460 0.261 58.50 0.342 
cisplatin 166.00 4.810 <200 1.290 <200 7.030 
The cytotoxicity of 1 & 2 along with the free phen ligand and the 
clinical antitumour agent cisplatin, were measured at 24 and 96hr 
intervals using a standard MTT assay against three progressive 
colorectal human-derived tumour cell lines (Table 3).† Both 10 
complexes display remarkable cytotoxicity against all three lines. 
Low-micromolar LD50 activities for both complexes were found 
after 24 hrs of exposure and, significantly, these activities 
reached the nano- and picomolar level after 96 hrs. As the 
colorectal tumour lines progress (HT29→SW480→SW620) 15 
activity of complex 1, over 96hrs, reduces from pico- to low 
micomolar, while the activity of 2 remained consistently in the 
low-mid nanomolar region. It is worth noting that while cisplatin 
displays significant low-micromolar cytotoxicity against all 
tumour lines after 96hrs, the activity of 1 & 2, in this period, is 20 
superior to this agent by a factor between 1x101 – 1x105.  
Cellular Reactive Oxygen Species (ROS) Study 
In order to elucidate the relationship between cytotoxicity and 
ROS generation, complexes 1 & 2, along with phen and cisplatin, 
were exposed to colorectal cancer cells, HT29, pre-treated with 25 
the intracellular ROS indicator 2′,7′-dichlorofluorescin diacetate 
(DCFH-DA).† In the presence of endogenously generated ROS, 
DCFH-DA becomes oxidised to release the fluorophore 2′,7′-
dichlorofluorescin (DFC). Results are expressed relative to the 
fluorescent response of the positive control (+Ctrl), hydrogen 30 
peroxide, which is considered a potent generator of ROS. 
Corrections were made using a negative control (-Ctrl), which 
represents the natural level of cellular ROS generated. Results 
were recorded at 15, 30, 60, 120 and 180 min intervals and are 
shown in Figure 6. Complex 2 was found to be an exceptional 35 
generator of ROS with greater activity relative to H2O2 (+Ctrl) 
across the concentration range 1000-250 nM and approximate 
equal activity to peroxide at 125 nM. It is worth commenting that 
this species was almost seven times more active than the next 
most effective ROS generator, phen. The activity of the 40 
copper(II) complex (1) was somewhat lower than both free phen 
and complex 2, indeed 1 needed to be assessed across a higher 
concentration range (100,000-195 nM). The clinical agent 
cisplatin was the least active of all tested compounds. This is 
unsurprising considering it is non-catalytic, it has also been well 45 
established that cisplatin only becomes cytotoxic upon its 
hydrolysis to [Pt(NH3)2(OH)2], which generally occurs between 
48-96 hrs.   
 
In vivo Drug Tolerance 50 
Larvae of the insect Galleria mellonella were employed to assess 
the in vivo cytotoxic tolerance of complexes 1 and 2, the ligand 
phen and the clinical antitumour agent cisplatin. Larvae of G. 
mellonella (the greater wax moth) have been widely used as a 
convenient and inexpensive in vivo screening model to assess the 55 
therapeutic potential of novel antimicrobial drugs.18, 19 They have 
yielded results that are considered comparable to those obtained 
using mammalian models.20 The innate defences of insects, 
including G. mellonella, like those of mammals consist of 
structural and passive barriers as well as humoral and cellular 60 
responses within the haemolymph (analogous to the blood of 
mammals).21 Indeed cellular responses within the haemolymph 
are often activated by signal transduction systems comparable to 
mice.22  
Table 4. % Kill of G. mellonella larvae after exposures of 5000-100 µg/mL of 65 
complexes 1 and 2, the ligand phen and the clinical antitumour drug cisplatin 
over the period 72 hours† Pauraic/Malachy we need to include ±SD 
values in this table. 
 % Kill of Galleria mellonella larve (72 hr) 
Concentration µg/mL (mg/kg body weight) 
 5000 (333) 2000 (133) 1000 (67) 500 (33) 200 (13) 
phen 100 90 80 0 0 
1 93.3 86.7 50 0 0 
2 93.3 93.3 40 0 0 
cisplatin 100 100 100 60 0 
 
Testing was carried out in triplicate using ten healthy 70 
G. mellonella larvae in the 6th developmental stage. Compounds 
were tested across the concentration range 5000-100 µg/mL (333-
13 mg/kg average body weight) with sterile test solutions being 
administered via hypodermic injection. Larvae were incubated at 
30°C for 72 hr with survival being monitored at 24 hr intervals 75 
and significance being determined using the log rank (Mantel-
Cox) method. Death was assessed by the lack of movement in 
response to stimulus together with discolouration. Results are 
presented (Table 4) as the mean % kill (± standard deviation) 
resulting from exposure to tested compound. Galleria exposed to 80 
high drug concentrations of 5000 and 2000 µg/mL showed poor 
tolerance to all tested species. However, at lower concentration 
ranges 1000-200 µg/mL significant differences were observed. 
Tolerance of Galleria larvae exposed to complexes 1 and 2 was 
highest of all tested species (50 and 40% kill at 67 mg/kg 85 
respectively, and 0% kill at 33 mg/kg). The clinical antitumour 
agent cisplatin was the poorest tolerated tested species with high 
toxicity (60% kill) being observed at 500 µg/mL (33 mg/kg). 
Encouragingly, the well-established rat LD50 of cisplatin (oral 
exposure) is reported as 25.8 mg/kg body weight, thus, it appears 90 
some agreement between these two models does exist.  
 
Proposed DNA Self-Cleaving Mechanism  
To conclude we would like to propose a mechanism by which of 
complex 1 self-activates the phosphodiester backbone in DNA 95 
via formation of a π carboxylate radical, concomitantly leading to 
the reduced formation of [Cu(phen)2]+ (Figure 7). Aliphatic 
carboxylate radicals are known to react by hydrogen abstraction 
in close competition with decarboxylation.23, 24 Generation of a π 
carboxylate radical within complex 1 would depend on the 100 
strength of the HOMO d orbital overlap on Cu2+ with the oxygen 
carboxylate. X-ray crystallography has revealed that the bond 
length between Cu-O in 1 is 1.974Å and is significantly shorter 
than the equivalent Mn-O bond in 2 which is 2.147 Å.13, 14 
Figure 6. Generation of endogenous reactive oxygen species (ROS) 
within the cancer cell line HT29 after exposure to; (a) the free 
ligand 1,10-phenanthroline, (b) the clinical antitumour agent 
cisplatin, (c) complex 1 and (d) complex 2.   
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However, since the Cu-O bond length may be altered when 1 
binds with DNA, it is impossible to know its exact length in vivo. 
 
 
 5 
Figure 7. Proposed mechanism of generating C-H bond activators (---) 
 
It is proposed the mechanism proceeds by the following 
steps: (i) after the binding of 1 to DNA, homolytic cleavage at the 
Cu-O bond generates the π carboxyl radical  10 
(---) and the reduced d10 complex [Cu(phen)2]+, the resultant 
carboxyl π radical undergoes rapid conversion to σ which  
decarboxylates to generate CO2 and R• (---); (ii) [Cu(phen)2]+ 
reacts, as is known, with O2 to generate the superoxide radical 
through an intermediate (---) yielding [Cu(phen)2]2+; (iii) complex 15 
1 or [Cu(phen)2]2+ subsequently react with O2•- to generate H2O2 
(as shown in Figure 5 & Table 2); (iv) since 1 does not 
disproportionate hydrogen peroxide (shown in Table 2) a 
subsequent reaction with H2O2 in (a) or O2 in (b) can generate 
known metal-oxo (---) and hydroxyl radical (---) bond activators. 20 
Since nuclease activity was detected in the presence of the 
chelator EDTA (Figure 4 (c)) it would stand to reason that the 
carboxylate radical or its breakdown product (R•) appears capable 
of abstracting H• from the phosphodiester backbone in DNA. In 
the absence of oxygen, the self-cleaving nuclease potential of 1 is 25 
diminished (Figure 4 (c)), and since, in the proposed mechanism, 
steps (ii)-(iv) are dependant on molecular oxygen, it also stands to 
reason that the nuclease potential should be reduced in the 
absence of these aerobically generated oxo- and hydroxo- bond 
activators. Futher efforts are currently underway in our laboratory 30 
to find further evidence for this proposed mechanism. 
 
Conclusions 
In summary, dinuclear Cu2+ and Mn2+ bis-phen complexes of the 
dicarboxylate, octanedioate, represent a significant advancement 35 
compared to existing metal-phenanthroline adducts. Their 
application as new water-soluble DNA-targeted 
chemotherapeutics is highly significant given their powerful and 
unprecedented cytotoxicity, encouraging in vivo drug tolerance 
and unique modes of action. While both complexes are avid 40 
binders of DNA, additionally, the copper(II) system has the 
capacity to self-cleave DNA, possibly through the generation of a 
π carboxyl radical, while the manganese(II) system is an 
exceptional redox catalyst that generates unprecedented levels of 
intracellular ROS within colon cancer cells.  45 
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